共 50 条
- [25] 177Lu-PSMA-617 for metastatic prostate cancer in India LANCET REGIONAL HEALTH - SOUTHEAST ASIA, 2024, 30
- [27] 177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial? European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 513 - 514